Last reviewed 2026-05-14 · How we verify

Matching Placebo for V116

This is a placebo control formulation with no active pharmaceutical ingredient, used as a comparator in clinical trials for V116.

At a glance

Mechanism of action

Matching placebos are inert formulations designed to be indistinguishable from the active drug in appearance, taste, and administration route. They serve as the control arm in randomized controlled trials to isolate the true therapeutic effect of the investigational drug V116 from placebo response and natural disease progression.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Matching Placebo for V116 CI brief — competitive landscape report
• Matching Placebo for V116 updates RSS · CI watch RSS
• Merck Sharp & Dohme LLC portfolio CI